IceCure Medical - 12 Year Stock Price History | ICCM
- The all-time high IceCure Medical stock closing price was 13.44 on May 05, 2021.
- The IceCure Medical 52-week high stock price is 1.66, which is 67.7% above the current share price.
- The IceCure Medical 52-week low stock price is 0.48, which is 51.5% below the current share price.
- The average IceCure Medical stock price for the last 52 weeks is 0.94.
IceCure Medical Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 1.2074 | 1.2300 | 1.5500 | 0.9700 | 0.9900 | -10.00% |
2024 | 0.9460 | 1.1600 | 1.4800 | 0.5290 | 1.1000 | 2.80% |
2023 | 1.0896 | 1.4100 | 1.4900 | 0.5402 | 1.0700 | -30.97% |
2022 | 1.8542 | 3.1000 | 3.3100 | 0.9366 | 1.5500 | -49.18% |
2021 | 7.3685 | 1.7600 | 13.4400 | 1.6184 | 3.0500 | 52.38% |
2020 | 1.8259 | 1.8400 | 2.4800 | 1.0400 | 2.0016 | 31.68% |
2019 | 1.5588 | 1.5975 | 1.5975 | 1.5200 | 1.5200 | 0.00% |
2016 | 1.1512 | 1.1512 | 1.1512 | 1.1512 | 1.1512 | -13.08% |
2015 | 1.3410 | 1.3574 | 1.3574 | 1.3245 | 1.3245 | -36.11% |
2014 | 4.2038 | 5.7587 | 5.7587 | 2.0731 | 2.0731 | -64.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.057B | $0.003B |
IceCure Medical Ltd. develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. IceCure Medical Ltd. is based in CAESAREA, Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $146.512B | 27.48 |
Elevance Health (ELV) | United States | $86.065B | 11.11 |
CVS Health (CVS) | United States | $83.137B | 10.33 |
Cencora (COR) | United States | $55.558B | 19.33 |
DiDi Global (DIDIY) | China | $23.015B | 24.45 |
Natera (NTRA) | United States | $22.771B | 0.00 |
BioMerieux (BMXMF) | France | $16.981B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $13.266B | 0.00 |
Solventum (SOLV) | United States | $12.874B | 13.63 |
ICON (ICLR) | Ireland | $11.753B | 10.93 |
CochLear (CHEOY) | Australia | $11.492B | 0.00 |
Revvity (RVTY) | United States | $11.324B | 19.49 |
Doximity (DOCS) | United States | $10.794B | 49.97 |
Viatris (VTRS) | United States | $10.540B | 3.62 |
Avantor (AVTR) | United States | $9.213B | 13.39 |
HealthEquity (HQY) | United States | $9.042B | 39.61 |
Medpace Holdings (MEDP) | United States | $8.689B | 23.08 |
Sonic Healthcare (SKHHY) | Australia | $8.397B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.422B | 14.54 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.425B | 26.06 |
BrightSpring Health Services (BTSG) | United States | $3.848B | 35.31 |
Sotera Health (SHC) | United States | $3.423B | 19.45 |
Alignment Healthcare (ALHC) | United States | $3.055B | 0.00 |
Surgery Partners (SGRY) | United States | $2.969B | 38.62 |
Concentras Parent (CON) | United States | $2.811B | 16.24 |
Organon (OGN) | United States | $2.620B | 2.78 |
GeneDx Holdings (WGS) | United States | $2.006B | 77.28 |
Ardent Health (ARDT) | United States | $1.908B | 8.13 |
Progyny (PGNY) | United States | $1.859B | 40.92 |
Premier (PINC) | United States | $1.853B | 14.06 |
GoodRx Holdings (GDRX) | United States | $1.618B | 32.36 |
PACS (PACS) | United States | $1.615B | 0.00 |
Teladoc Health (TDOC) | United States | $1.302B | 0.00 |
Pediatrix Medical (MD) | United States | $1.222B | 9.29 |
CareDx (CDNA) | United States | $1.118B | 17.46 |
Establishment Labs Holdings (ESTA) | $1.114B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
Agilon Health (AGL) | United States | $0.948B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.844B | 7.90 |
QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
Nutex Health (NUTX) | United States | $0.671B | 10.16 |
Embecta (EMBC) | United States | $0.591B | 3.98 |
LifeMD (LFMD) | United States | $0.574B | 0.00 |
Enhabit (EHAB) | United States | $0.519B | 42.71 |
InnovAge Holding (INNV) | United States | $0.514B | 0.00 |
SBC Medicals (SBC) | United States | $0.481B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.462B | 10.40 |
COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
Oncology Institute (TOI) | United States | $0.255B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.252B | 0.00 |
Beauty Health (SKIN) | United States | $0.200B | 0.00 |
DocGo (DCGO) | United States | $0.156B | 25.50 |
KindlyMD (KDLY) | United States | $0.150B | 0.00 |
KindlyMD (NAKA) | United States | $0.111B | 0.00 |
Pheton Holdings (PTHL) | China | $0.109B | 0.00 |
So-Young (SY) | China | $0.091B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.077B | 0.00 |
OncoCyte (OCX) | United States | $0.076B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.058B | 0.00 |
Sera Prognostics (SERA) | United States | $0.057B | 0.00 |
ModivCare (MODV) | United States | $0.052B | 0.00 |
OpGen (OPGN) | United States | $0.050B | 0.00 |
Biodesix (BDSX) | United States | $0.047B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
INVO Fertility (IVF) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |